Biopharmaceutical companies have been seeing the importance of sustainability and green efforts. Two companies in particular have embraced sustainability and green manufacturing.
Biopharmaceutical companies have been seeing the importance of sustainability and green efforts. Two companies in particular have embraced sustainability and green manufacturing.
As part of a five-year goal to reduce its greenhouse gas emissions by 20%, Millipore (Billerica, MA) has instituted an energy program that includes efficiency, renewable energy installation and purchase, employee communications, and careful measurement of results. On March 18 at Interphex, David Newman, director of environment, health, and safety, (EHS) and sustainability, will illustrate how Millipore has dramatically reduced its electricity usage—and carbon footprint—through the implementation of this multi-faceted approach. Newman will detail several new projects and discuss the environmental, economic, and social benefits that have resulted from each.
Newman leads Millipore’s CEO-sponsored Sustainability Initiative, which addresses waste and product stewardship. As director of EHS and Sustainability, Newman leads a staff of 75 professionals worldwide, addressing issues of environment, health, safety and facilities. Under Newman’s leadership, Millipore has reduced energy consumption by 10% since 2007, adopted a hybrid vehicle fleet, developed two LEED building projects and lowered annual water usage by 40 million gallons.
Baxter International Inc. (Deerfield, IL) is also an industry leader in sustainability efforts. In January, the company was included in the Global 100 Most Sustainable Corporations in the World. Baxter is one of four healthcare companies globally and the only US healthcare, to have been recognized in the Global 100 each year since the list was first in 2005 by Innovest Strategic Value Advisors, an international investment research and advisory firm.
Baxter’s Thousand Oaks, CA, facility was honored in the energy efficiency category of California’s statewide energy efficiency campaign; the Cleveland, MS, facility was selected to participate in the state’s enHance program, a voluntary state incentive program that encourages environmental stewardship and recognizes environmental leaders, and the Round Lake, IL facility was recognized with a Pollution Prevention Award from the state of Illinois.
Baxter was also featured in the new book “Green Biz: 50 Green, Profitable Companies Reveal Their Strategies and Successes” for its leadership in sustainability. The book was compiled by Ceres—the largest coalition of investors, environmental organizations, and investment funds that engages directly with companies, including Baxter, on environmental and social issues.
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
May 14th 2025Imagine a world where cleanroom facilities—essential for pharmaceutical manufacturing, biotechnology, and high-tech industries—are built with unparalleled speed, precision, and efficiency. That world is here, thanks to the hybrid construction approach. By blending traditional stick-built methods with modular and prefabricated solutions, companies are overcoming the limitations of conventional construction while ensuring compliance with stringent industry regulations. In this interview, we explore how hybrid cleanroom construction is transforming the industry, offering faster project timelines, improved quality control, and significant cost advantages. Join us as we delve into this game-changing approach with industry experts who are leading the charge in revolutionizing cleanroom infrastructure.
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.